AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius SE & Co. KGaA

M&A Activity Apr 7, 2017

166_rns_2017-04-07_fa5d618f-51ec-4c53-9547-70f97719d7cb.html

M&A Activity

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 7 April 2017 22:54

Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms discussions with Akorn, Inc.

Fresenius SE & Co. KGaA / Key word(s): Mergers & Acquisitions

07-Apr-2017 / 22:54 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Fresenius SE & Co. KGaA confirms that Fresenius Kabi is currently in discussions with Akorn, Inc., a US specialty generic pharmaceutical company, concerning a potential acquisition of Akorn, Inc. Akorn, Inc. shares are listed on the NASDAQ Global Select Market.

Entry into a formal agreement of a transaction remains subject to, among other things, approval by the Executive Board and Supervisory Board of Fresenius Management SE and the board of directors of Akorn, Inc. There can be no assurance any transaction will result from these discussions, or as to the terms of any such transaction. Neither Fresenius SE & Co. KGaA nor Akorn, Inc. intend to make any additional comments regarding these negotiations unless and until it is appropriate to do so, or a formal agreement has been reached.

Fresenius SE & Co. KGaA,

represented by Fresenius Management SE

The Executive Board

Bad Homburg v.d.H., 7 April 2017

Contact:

Markus Georgi

Senior Vice President Investor Relations

T: +49 (0) 6172 608-2485

[email protected]

End of note


07-Apr-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: [email protected]
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxemburg
End of Announcement DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.